Sunwin Stevia International, Inc. engages in the manufacture and sale of neutraceutical products. The company is headquartered in Jining, Shandong and currently employs 242 full-time employees. The company went IPO on 2002-11-13. The firm operates through two segments related to its product lines: Stevioside, which produces and sells a range of purified steviol glycosides with rebaudioside A and stevioside as the principal components; a natural, low calorie sweetener, and OnlySweet, a stevioside-based table top sweetener, and Chinese medicines, which manufactures and sells traditional Chinese medicine formula extracts, which are used in products made for use by both humans and animals. The firm engages in new product development both through its internal research facilities, industry consultants and specialists to provide research and development for the planting of stevia plants, for the development of biological methods to improve lower-grade stevia product to higher-grade stevia, and for the application of biological method to change the taste of stevia.

Industry: Pharmaceutical Preparations Peers: China Pharma Holdings Inc China SXT Pharmaceuticals Inc BGM Group Ltd Universe Pharmaceuticals Inc